-
1 Comment
The Biotech Growth Trust PLC is currently in a long term downtrend where the price is trading 6.5% below its 200 day moving average.
From a valuation standpoint, the stock is 95.7% cheaper than other stocks from the Financial Services sector with a price to sales ratio of 2.3.
The Biotech Growth Trust PLC's total revenue sank by 0.0% to $9M since the same quarter in the previous year.
Its net income has dropped by 0.0% to $-11M since the same quarter in the previous year.
Finally, its free cash flow fell by 4.6% to $-1M since the same quarter in the previous year.
Based on the above factors, The Biotech Growth Trust PLC gets an overall score of 1/5.
| Sector | Financial Services |
|---|---|
| Industry | Asset Management |
| Exchange | LSE |
| CurrencyCode | GBP |
| ISIN | GB0000385517 |
| Market Cap | 185M |
|---|---|
| PE Ratio | 2.55 |
| Target Price | None |
| Beta | 0.5 |
| Dividend Yield | None |
The Biotech Growth Trust PLC is a closed ended equity mutual fund launched by Frostrow Capital LLP. It is co-managed by OrbiMed Capital LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the biotechnology sector. The fund invests in stocks of companies across all market capitalizations. It employs fundamental analysis to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotechnology Index. It was previously known as Finsbury Emerging Biotechnology Trust PLC. The Biotech Growth Trust PLC was formed on May 20, 1997 and is domiciled in the United Kingdom.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for BIOG.LSE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
